Jean-Hugues Brossard

Direttore/Membro del Consiglio presso GLWL Research, Inc.

Health Services

Provenienza dei contatti di primo grado di Jean-Hugues Brossard

Entità	Tipo di entità	Settore Industriale
GLWL Research, Inc. GLWL Research, Inc. Medical/Nursing ServicesHealth Services GLWL Research, Inc. is a medical research laboratory. It develops and proofs compounds for treatment of diabetes where it has developed an investigational compound known as GLWL-01 to treat type-2 diabetes. The company is headquartered in Montreal, Canada. 4	Holding Company	Medical/Nursing Services	4

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a Jean-Hugues Brossard tramite i suoi contatti personali

Società	Settore	Persone collegate	Posizione principale
AETERNA ZENTARIS INC.	Pharmaceuticals: Major	Marc Rivière	Corporate Officer/Principal
TELESTA THERAPEUTICS INC	Pharmaceuticals: Other	Marc Rivière	Chief Tech/Sci/R&D Officer
PricewaterhouseCoopers LLP PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY.	Miscellaneous Commercial Services	Mark G. Cipriano	Comptroller/Controller/Auditor
Esperas Pharma Inc. Esperas Pharma Inc. Pharmaceuticals: MajorHealth Technology Esperas Pharma, Inc. manufactures and develops pharmaceutical products. The firm is created to develop one compound to proof-of-concept. It plans to develop, to proof-of-concept, a compound originally discovered through one of Lilly’s research and development programs, with the potential to treat certain types of cancers including triple negative breast cancer. The company was founded in 2015 and is headquartered in Montreal, Canada.	Pharmaceuticals: Major	Mark G. Cipriano Marc Rivière Caroline Fortier	Director of Finance/CFO Director/Board Member Chief Executive Officer
Ascent Venture Management Inc. Ascent Venture Management Inc. Investment ManagersFinance Ascent Venture Management Inc (Ascent Venture Partners) is a venture capital firm founded in 1985. The firm is headquartered in Boston, Massachusetts.	Investment Managers	Mark G. Cipriano	Director of Finance/CFO
Société Générale de Promotion & de Financement Immobiliers SA Société Générale de Promotion & de Financement Immobiliers SA Real Estate DevelopmentFinance Société Générale de Promotion & de Financement Immobiliers SA provides real estate services. It offers renting, buying, selling and appraising real estate. The company is headquartered in Courbevoie, France.	Real Estate Development	Caroline Fortier	Chief Executive Officer
Université Laval	College/University	Caroline Fortier	Doctorate Degree
Access Vascular, Inc. Access Vascular, Inc. Medical SpecialtiesHealth Technology Access Vascular, Inc. engages in the development and manufacture of medical devices. It provides hydrogel-based medical devices, such as catheter and stenst to improve venous access. The firm also improves peripherally inserted central catheter, hemodialysis, implantable ports, and drug delivery devices. The company was founded by James Biggins in 2015 and is headquartered in Bedford, MA.	Medical Specialties	Marc Rivière	Director/Board Member
ImmunoRx Pharma, Inc. ImmunoRx Pharma, Inc. Pharmaceuticals: MajorHealth Technology ImmunoRx Pharma, Inc. manufactures pharmaceutical products. The company is based in Wilmington, DE. The CEO of the company is Juan Felipe Velasquez.	Pharmaceuticals: Major	Marc Rivière	Director/Board Member
Quintiles, Inc. (California) Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA.	Medical/Nursing Services	Marc Rivière	Corporate Officer/Principal
XENON PHARMACEUTICALS INC.	Pharmaceuticals: Major	Marc Rivière	Chief Executive Officer
Festival Classica, Inc. Festival Classica, Inc. Media ConglomeratesConsumer Services Festival Classica, Inc. conducts events and musical shows. The private company is based in Saint-Lambert, Canada.	Media Conglomerates	Marc Rivière	Director/Board Member
MRCL, Inc. MRCL, Inc. Miscellaneous Commercial ServicesCommercial Services MRCL, Inc. provides research laboratory services. The private company is based in Montréal, Canada. The Canadian company was founded by Marc Rivière.	Miscellaneous Commercial Services	Marc Rivière	Founder
Optina Diagnostics, Inc. Optina Diagnostics, Inc. Medical SpecialtiesHealth Technology Optina Diagnostics, Inc. manufactures retinal diagnostic imaging devices to detect alzheimer's diseases. The company is headquartered in Montréal, Canada.	Medical Specialties	Marc Rivière	Director/Board Member
AL-S Pharma AG AL-S Pharma AG Pharmaceuticals: MajorHealth Technology AL-S Pharma AG engages in the development and marketing of pharmaceutical products. The company was founded by Michael Salzmann on September 19, 2016 and is headquartered in Schlieren, Switzerland.	Pharmaceuticals: Major	Marc Rivière	Director/Board Member
Université Toulouse III - Paul Sabatier	College/University	Marc Rivière	Doctorate Degree
Université de Bordeaux	College/University	Marc Rivière	Undergraduate Degree
ABIONYX PHARMA	Pharmaceuticals: Major	Marc Rivière	Director/Board Member
RAPID MICRO BIOSYSTEMS, INC.	Industrial Machinery	Mark G. Cipriano	Director/Board Member
Suffolk University	College/University	Mark G. Cipriano	Undergraduate Degree
TVM Capital Corp. TVM Capital Corp. Investment ManagersFinance TVM Capital Corp (TVM Capital) is a venture capital subsidary of TVM Capital GmbH founded in 1986. The firm is headquartered in Boston, Massachusetts.	Investment Managers	Mark G. Cipriano	Chief Investment Officer